Adagio Therapeutics, Inc. Intellectual Property Contracts & Agreements
2 Contracts & Agreements
- License Agreements (2 contracts)
- Cell Line License Agreement by and between the Registrant and WuXi Biologics (Hong Kong) Limited, dated December 2, 2020 (Filed With SEC on July 16, 2021)
- Assignment and License Agreement by and between the Registrant and Adimab, LLC, dated July 8, 2020 (Filed With SEC on July 16, 2021)
